Subtype
Large Intestinal Neoplasm
CI-CAN-00001062Explore in graph →
Non-malignant1,847 active trials21 approved drugs383 evidence items
- NCIt
- C215201
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001062Explore in graph →
Clinical trials
8,849 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01384994 | Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients | unknown | Phase 2 | 111 | PD Dr. med. Volker HeinemannOTHER | 1 | Jul 9, 2012 | clinicaltrials |
| NCT00055822 | Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | 16 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jul 4, 2012 |
| clinicaltrials |
| NCT00005833 | S9923 R115777 in Treating Patients With Advanced Colorectal Cancer | completed | Phase 2 | 62 | SWOG Cancer Research NetworkNETWORK | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00792363 | Irinotecan and Panitumumab as 3rd Line Treatment for mCRC Without KRAS Mutations | completed | Phase 2 | 32 | Vejle HospitalOTHER | 1 | Jun 13, 2012 | clinicaltrials |
| NCT00070434 | S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum | withdrawn | Phase 2 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Jun 7, 2012 | clinicaltrials |
| NCT00313794 | Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After Treatment | completed | Phase 2 | 49 | AstraZenecaINDUSTRY | 2 | Jun 7, 2012 | clinicaltrials |
| NCT00004895 | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004910 | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00004911 | Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction | completed | Phase 1 / Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00217711 | Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | completed | Phase 1 / Phase 2 | 23 | Swiss Cancer InstituteOTHER | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00227734 | Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | completed | Phase 2 | 74 | Swiss Cancer InstituteOTHER | 1 | Jun 5, 2012 | clinicaltrials |
| NCT00080834 | DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma | completed | Phase 2 | — | Daiichi SankyoINDUSTRY | 1 | May 16, 2012 | clinicaltrials |
| NCT00030797 | Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | 75 | Swiss Cancer InstituteOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00089401 | Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver | completed | Phase 2 | 8 | National Institutes of Health Clinical Center (CC)NIH | 1 | May 14, 2012 | clinicaltrials |
| NCT01591798 | Efficacy Study of Robotic Surgery for Rectal Cancer | unknown | Phase 2 | 146 | National Cancer Center, KoreaOTHER_GOV | 1 | May 7, 2012 | clinicaltrials |
| NCT00286130 | Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 150 | Central European Cooperative Oncology GroupOTHER | 13 | May 1, 2012 | clinicaltrials |
| NCT01129700 | Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer | completed | Phase 2 | 73 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 27, 2012 | clinicaltrials |
| NCT00824161 | Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer | terminated | Phase 2 | 28 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 23, 2012 | clinicaltrials |
| NCT01109615 | Pemetrexed and Gemcitabine for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations(PG) | terminated | Phase 2 | 40 | Vejle HospitalOTHER | 1 | Apr 19, 2012 | clinicaltrials |
| NCT01574027 | Efficacy of Vitamin D in Colorectal Cancer Chemoprevention | completed | Phase 2 | 55 | University of Illinois at ChicagoOTHER | 1 | Apr 10, 2012 | clinicaltrials |
| NCT01552967 | Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal Adenocarcinoma(mXELOX) | unknown | Phase 2 | 30 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT00689702 | Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer(XERT) | unknown | Phase 2 | 43 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00842686 | Preoperative Radiotherapy With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer: CRAB Phase II Study(CRAB) | unknown | Phase 2 | 60 | Institute of Oncology LjubljanaOTHER | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00019786 | Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases | completed | Phase 2 | 67 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00503932 | Proton Therapy With Capecitabine for Rectal Cancer | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Mar 22, 2012 | clinicaltrials |
| NCT01387880 | Irinotecan, Cetuximab and Everolimus to Patients With Metastatic Colorectal Cancer(ICE) | completed | Phase 2 | 100 | Herlev HospitalOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00137683 | Colorectal Cancer Control in Appalachian Churches | withdrawn | Phase 2 / Phase 3 | 0 | Centers for Disease Control and PreventionFED | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01064999 | A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer | unknown | Phase 2 / Phase 3 | 240 | Fudan UniversityOTHER | 1 | Mar 14, 2012 | clinicaltrials |
| NCT00003254 | SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil | completed | Phase 2 | 75 | SWOG Cancer Research NetworkNETWORK | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00110721 | GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer | terminated | Phase 2 | 20 | Galectin Therapeutics Inc.INDUSTRY | 2 | Mar 6, 2012 | clinicaltrials |
| NCT00786643 | Study of Gamma Interfereon in Metastatic Colorectal Carcinoma(GFL) | completed | Phase 2 | 48 | Accelerated Community Oncology Research NetworkOTHER | 1 | Mar 1, 2012 | clinicaltrials |
| NCT00137878 | TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer | completed | Phase 2 | — | GenVecINDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00176774 | Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma | completed | Phase 2 | 24 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00609310 | Dietary Bioflavonoid Supplementation for the Prevention of Neoplasia Recurrence | suspended | Phase 2 | 382 | Technische Universität DresdenOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT00313859 | Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC | completed | Phase 2 | 50 | Samsung Medical CenterOTHER | 1 | Feb 2, 2012 | clinicaltrials |
| NCT00969033 | CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin | terminated | Phase 2 | 8 | Daiichi SankyoINDUSTRY | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00122291 | A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer | unknown | Phase 2 | 66 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT00690677 | Phase II Trial of LBH589 in Refractory Colorectal Cancer | completed | Phase 2 | 29 | Swedish Medical CenterOTHER | 1 | Jan 18, 2012 | clinicaltrials |
| NCT00891332 | Study of S-1 Plus LV for Untreated Metastatic Colorectal Cancer | completed | Phase 2 | 73 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 2 | Jan 18, 2012 | clinicaltrials |
| NCT00297128 | Preoperative Chemoradiation With Capecitabine and Cetuximab | completed | Phase 2 | 31 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Dec 30, 2011 | clinicaltrials |
| NCT01042743 | Laparoscopic Surgery Versus Robot Surgery for Right-side Colon Cancer: Short-term Outcome of a Randomised Clinical Trial | completed | Phase 2 | 80 | Kyungpook National University HospitalOTHER | 1 | Dec 20, 2011 | clinicaltrials |
| NCT00422864 | A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer | completed | Phase 2 | 26 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Dec 15, 2011 | clinicaltrials |
| NCT01489332 | Induction Chemotherapy,Radiochemotherapy, Consolidation Chemotherapy in Preoperative Treatment of Rectal Cancer | unknown | Phase 2 | 60 | Institute of Oncology LjubljanaOTHER | 1 | Dec 9, 2011 | clinicaltrials |
| NCT01175291 | FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer | withdrawn | Phase 2 | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Dec 5, 2011 | clinicaltrials |
| NCT01155440 | Bowel Function After Laparoscopic Colon Surgery: Effect of IV Lidocaine | completed | Phase 2 | 60 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT01477190 | Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program | completed | Phase 1 / Phase 2 | 40 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT00866944 | Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases(MT201-204) | completed | Phase 2 | 35 | Amgen Research (Munich) GmbHINDUSTRY | 2 | Nov 11, 2011 | clinicaltrials |
| NCT00354978 | Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients | completed | Phase 2 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT01070355 | Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver Metastases(EMT) | completed | Phase 2 | 88 | University of LeedsOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT00668863 | Study Of Sunitinib With FOLFIRI In Colorectal Cancer | completed | Phase 2 | 71 | PfizerINDUSTRY | 1 | Oct 17, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Jul 9, 2012source: clinicaltrials